Nanoform Finland Oyj (FRA:4YL)
Germany · Delayed Price · Currency is EUR 0.9470
+0.0360 (3.95%)
Last updated: Nov 27, 2025, 9:09 AM CET
Nanoform Finland Oyj Company Description
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.
The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances.
It also offers STARMAP, an online platform to pick winners among candidate molecules for CESS powered nanoforming.
The company was founded in 2008 and is headquartered in Helsinki, Finland.
Nanoform Finland Oyj
| Country | Finland |
| Founded | 2008 |
| Industry | Commercial Physical and Biological Research |
| Employees | 181 |
| CEO | Edward Haeggstrom |
Contact Details
Address: Cultivator II Helsinki, 00790 Finland | |
| Phone | 358 2937 00150 |
| Website | nanoform.com |
Stock Details
| Ticker Symbol | 4YL |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Edward Haeggstrom | Chief Executive Officer |
| Albert Haeggstrom | Chief Financial Officer |
| Henri von Haartman | Head of Investor Relations |